FdaApplication

NDA 016084

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCASPER PHARMA LLC
application_typeNDA
approval_date2022-08-04

Products (3)

ProductActive ingredientStrengthDosage form
ZYLOPRIMALLOPURINOL300MGTABLET;ORAL
ZYLOPRIMALLOPURINOL100MGTABLET;ORAL
ZYLOPRIMALLOPURINOL200MGTABLET;ORAL

3 products